Jürg Reichen #


Education and Professional Experience
  • 1960 - 1964 Städtisches Gymnasium Burgdorf, Switzerland, Maturity type A
  • 1964 - 1971 Medical School, University of Berne, Switzerland
  • Jan 1972 - Dec 1972 Fellow in Pharmacology, Department of Experimen­tal Medicine, Hoffmann-LaRoche AG, Basel, Switzerland
  • Jan 1973 - June 1976 Fellow in Clinical Pharmacology and Hepatology, Department of Clinical Pharmacology, University of Berne, Switzerland (Prof. R. Preisig)
  • July 1976 - June 1978 Guest Scientist, Liver Unit, DDB, National Institutes of Health, Bethesda, MD, U.S.A. Training in Hepatology (Prof. P.D. Berk) and Hepatopathology (Prof. and Prof. K.G. Ishak)
  • July 1978 - June 1979 Intern and Resident in Medicine, Georgetown University and Veterans Administration Hospital, Washington, DC, U.S.A.
  • July 1979 - June 1980 Fellow in Gastroenterology, University of Colorado School of Medicine, Denver, CO, U.S.A.
  • July 1980 - June 1984 Assistant Professor of Medicine, Appointment in Internal Medicine, Clinical Pharmacology and Gastroenterology, University of Colorado School of Medicine, Denver, CO, U.S.A. Training in transplant hepatology (Prof. T.E. Starzl)
  • July 1984 - July 1985 Associate Professor of Medicine, University of Colorado Medical School, Denver, CO, U.S.A.
  • November 1984 Venia docendi, University of Berne
  • April 1986 Professor of Medicine and Clinical Pharmacology, University of Berne
  • October 1994 - 1999 Co-Director, Department of Clinical Research
  • October 1994 – December 2007 Co-Director, Department of Clinical Pharmacology
  • 1998 - 1999 Associate Dean for Research, Faculty of Medicine
  • 2000 - 2001 Chairman, Kuratorium Department of Clinical Research
  • 2001 – present Chief, Hepatology, University Hospital Inselspital, Berne
  • January 2008 – present Chief, Hepatology and Co-Director, University Clinic for Visceral Surgery and Medicine, University Hospital Inselspital, Berne

Academic Honors and Awards
  • January 9, 1975 Doctor medicinae, Faculty of Medicine, University of Berne, Berne, Switzerland
  • June 1, 1976 Prize of the Faculty of Medicine, University of Berne for thesis: "Uptake of Bile Acids by the Perfused Rat Liver"
  • July 1, 1976 Fellowship (2 years) of the Swiss National Foundation for Scientific Research
  • July 1, 1981 Faculty Development Award in Clinical Pharmacology (2 years), The Pharmaceutical *Manufacturers' Association Foundation, Washington, DC, U.S.A.
  • August 1, 1983 Research Career Development Award (5 years), National Institutes of Health, U.S.A.
  • July 1, 1984 Research Career Development Award (6 years), Swiss National Foundation for Scientific Research
  • 1987 Prize of the Swiss Society for Internal Medicine
  • 1987 Prize of the Swiss Society for Gastroenterology
  • 1995 Cloëtta Prize
  • 2002 Lucie Bolte Prize
  • 2008 EASL recognition award

Professional Societies
  • 1972 Swiss Society of Physicians
  • 1977 American Federation for Clinical Research
  • 1981 American Association for the Study of Liver Diseases
  • 1982 American Gastroenterological Association
  • 1983 Western Society for Clinical Investigation
  • 1983 Gastroenterology Research Group
  • 1984 International Association for the Study of the Liver
  • 1985 Schweizerische Gesellschaft für Pharmakologie und Toxikologie
  • 1985 Schweizerische Gesellschaft für Klinische Pharmakologie
  • 1985 European Association for the Study of the Liver
  • 1985 Schweizerische Gesellschaft für Gastroenterologie & Hepatologie
  • 1985 European Society for Biochemical Pharmacology
  • 1985 Cofounder, European Liver Transport Study Group
  • 1986 Cofounder of the Swiss Association for the Study of the Liver
  • 1987 New York Academy of Sciences
  • 2000 Academia Europaea

Licensure
  • 1971 Swiss Federal Medical Board
  • 1971 ECFMG
  • 1981 Colorado License No. 23695 (by FLEX examination)

Offices, Public Service
  • 1983 Nominations Committee, AASLD
  • 1983 Special Study Section, NIH
  • 1984 - 1985 Research Committee, AASLD
  • 1986 - 1996 Federal Expert Commission on classification of toxic compounds
  • 1986 - 1993 Secretary SASL
  • 1987 - 1994 Associate Editor, Pharmacology and Therapeutics
  • 1988 - 1991 Scientific Committee, EASL
  • 1988 - 1994 Editorial Board, Hepatology
  • 1989 - 1991 Secretary, EASL
  • 1989 - 1993 Associate Editor, Journal of Hepatology
  • 1989 - 1992 Federal Commission for a MD/PhD program in Switzerland
  • 1990 - 1993 Counsillor, United European Gastroenterology Federation
  • 1992 - 1997 European Hepatitis Education Council
  • 1992 - present Trustee, Sandoz Research Foundation
  • 1992 - 1996 Counsillor, International Association for the Study of the Liver
  • 1992 - 1994 Vice-president, Swiss Society for Gastroenterology and Hepatology
  • 1994 - 1996 Associate Editor, Hepatology
  • 1996 - 1999 Editorial board, Journal of Hepatology
  • 1999 - 2005 European Scientific Committee of Orphanet, co-editor hepatology
  • 1998 - 2004 Associate Editor, J. Hepatology
  • 2002 - present Editorial Board member, BMC Comparative Hepatology
  • 2003 – 2007 Councillor for Education, EASL

Imprint Privacy policy « This page (revision-7) was last changed on Wednesday, 11. January 2017, 14:48 by Kaiser Dana
  • operated by